$TIVC
Tivic Health Systems, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022025033 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $408.0K $477.0K $253.0K
YoY Change 11.48% 88.54% 4.12%
Cost Of Revenue $365.0K $414.0K $302.0K
YoY Change -6.65% 37.09% 1.0%
Gross Profit $43.00K $63.00K -$49.00K
YoY Change -272.0% -228.57% -12.5%
Gross Profit Margin 10.54% 13.21% -19.37%
Selling, General & Admin $1.864M $2.248M $1.009M
YoY Change -4.8% 122.79% 74.57%
% of Gross Profit 4334.88% 3568.25%
Research & Development $435.0K $399.0K $171.0K
YoY Change 41.23% 133.33% -5.0%
% of Gross Profit 1011.63% 633.33%
Depreciation & Amortization $3.000K $3.000K $2.000K
YoY Change 50.0% 50.0% -66.67%
% of Gross Profit 6.98% 4.76%
Operating Expenses $2.299M $2.647M $1.180M
YoY Change 1.46% 124.32% 55.67%
Operating Profit -$2.256M -$2.584M -$1.229M
YoY Change -1.53% 110.25% 50.98%
Interest Expense $1.000K $1.000K -$1.094M
YoY Change -99.51% -100.09% 796.72%
% of Operating Profit
Other Income/Expense, Net $1.000K $0.00 $3.000K
YoY Change -100.0% 200.0%
Pretax Income -$2.254M -$2.584M -$2.320M
YoY Change -39.47% 11.38% 148.13%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.254M -$2.600M -$2.320M
YoY Change -39.47% 12.07% 148.13%
Net Earnings / Revenue -552.45% -545.07% -917.0%
Basic Earnings Per Share -$0.27 -$0.90
Diluted Earnings Per Share -$0.23 -$0.27 -$250.4K
COMMON SHARES
Basic Shares Outstanding 9.678M 9.678M 2.578M
Diluted Shares Outstanding 9.678M 2.578M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.517M $6.328M $848.0K
YoY Change -72.89% 646.23%
Cash & Equivalents $3.500M $6.300M $848.0K
Short-Term Investments
Other Short-Term Assets $819.0K $410.0K $110.0K
YoY Change -1.8% 272.73%
Inventory $863.0K $761.0K $290.0K
Prepaid Expenses
Receivables $88.00K $95.00K $150.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $5.287M $7.594M $1.398M
YoY Change -63.0% 443.2%
LONG-TERM ASSETS
Property, Plant & Equipment $12.00K $15.00K $13.00K
YoY Change 9.09% 15.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $34.00K $34.00K $570.0K
YoY Change -30.61% -94.04%
Total Long-Term Assets $569.0K $614.0K $583.0K
YoY Change -23.83% 5.32%
TOTAL ASSETS
Total Short-Term Assets $5.287M $7.594M $1.398M
Total Long-Term Assets $569.0K $614.0K $583.0K
Total Assets $5.856M $8.208M $1.981M
YoY Change -61.05% 314.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.323M $1.602M $1.299M
YoY Change 67.68% 23.33%
Accrued Expenses $536.0K $421.0K $318.0K
YoY Change 24.65% 32.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.985M
YoY Change
Total Short-Term Liabilities $1.859M $2.023M $5.593M
YoY Change 52.5% -63.83%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.180M
YoY Change -100.0%
Other Long-Term Liabilities $367.0K $413.0K
YoY Change -32.66%
Total Long-Term Liabilities $367.0K $413.0K $2.180M
YoY Change -32.66% -81.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.859M $2.023M $5.593M
Total Long-Term Liabilities $367.0K $413.0K $2.180M
Total Liabilities $2.226M $2.436M $7.773M
YoY Change 26.19% -68.66%
SHAREHOLDERS EQUITY
Retained Earnings -$29.60M -$27.40M
YoY Change 51.44%
Common Stock $1.000K $1.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.630M $5.772M -$5.792M
YoY Change
Total Liabilities & Shareholders Equity $5.856M $8.208M $1.981M
YoY Change -61.05% 314.34%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$2.254M -$2.600M -$2.320M
YoY Change -39.47% 12.07% 148.13%
Depreciation, Depletion And Amortization $3.000K $3.000K $2.000K
YoY Change 50.0% 50.0% -66.67%
Cash From Operating Activities -$2.227M -$2.772M -$1.644M
YoY Change -19.31% 68.61% -32.98%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$5.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$5.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $56.00K
YoY Change 409.09%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -584.0K 56.00K 869.0K
YoY Change -103.92% -93.56% 11.27%
NET CHANGE
Cash From Operating Activities -2.227M -2.772M -1.644M
Cash From Investing Activities 0.000 -5.000K
Cash From Financing Activities -584.0K 56.00K 869.0K
Net Change In Cash -2.811M -2.721M -775.0K
YoY Change -123.18% 251.1% -53.65%
FREE CASH FLOW
Cash From Operating Activities -$2.227M -$2.772M -$1.644M
Capital Expenditures $0.00 -$5.000K
Free Cash Flow -$2.227M -$2.767M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001787740
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41052
dei Entity Registrant Name
EntityRegistrantName
Tivic Health Systems, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4016391
dei Entity Address Address Line1
EntityAddressAddressLine1
25821 Industrial Blvd.,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Hayward
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94545
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
276-6888
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
TIVC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9677734
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6328000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12975000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92000
CY2022Q3 us-gaap Inventory Net
InventoryNet
761000
CY2021Q4 us-gaap Inventory Net
InventoryNet
429000
CY2022Q3 us-gaap Deferred Offering Costs
DeferredOfferingCosts
79000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
331000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
793000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
7594000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14289000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
15000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
565000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
687000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
34000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49000
CY2022Q3 us-gaap Assets
Assets
8208000
CY2021Q4 us-gaap Assets
Assets
15036000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1602000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
789000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
261000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
267000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
160000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
163000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2023000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1219000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
413000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
545000
CY2022Q3 us-gaap Liabilities
Liabilities
2436000
CY2021Q4 us-gaap Liabilities
Liabilities
1764000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9677734
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9677734
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9715234
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9715234
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
1000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33159000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32817000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27388000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19546000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5772000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13272000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8208000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15036000
CY2022Q3 us-gaap Revenues
Revenues
477000
CY2021Q3 us-gaap Revenues
Revenues
277000
us-gaap Revenues
Revenues
1432000
us-gaap Revenues
Revenues
868000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
414000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
303000
us-gaap Cost Of Revenue
CostOfRevenue
1176000
us-gaap Cost Of Revenue
CostOfRevenue
904000
CY2022Q3 us-gaap Gross Profit
GrossProfit
63000
CY2021Q3 us-gaap Gross Profit
GrossProfit
-26000
us-gaap Gross Profit
GrossProfit
256000
us-gaap Gross Profit
GrossProfit
-36000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
399000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
175000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1295000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
1203000
us-gaap Operating Expenses
OperatingExpenses
8098000
us-gaap Operating Expenses
OperatingExpenses
3305000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
565000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
487000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
450000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2291000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1095000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1761000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
578000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7842000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4512000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1645000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2647000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1229000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2584000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3341000
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1171000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
1000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-1668000
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
80000
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
81000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
158000
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1091000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1429000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2584000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2320000
us-gaap Net Income Loss
NetIncomeLoss
-7842000
us-gaap Net Income Loss
NetIncomeLoss
-4770000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.27
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.27
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.81
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.81
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.96
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9677734
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9677734
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2578180
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2578180
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9671347
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9671347
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2429939
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2429939
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1177000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6000
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
10000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1356000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2517000
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
8000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-1094000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-3603000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
52000
CY2021Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
23000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2320000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-5792000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13272000
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
61000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2240000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11093000
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
112000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3018000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
8187000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation Noncash
EmployeeBenefitsAndShareBasedCompensationNoncash
113000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2584000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
5772000
us-gaap Profit Loss
ProfitLoss
-7842000
us-gaap Profit Loss
ProfitLoss
-4770000
us-gaap Share Based Compensation
ShareBasedCompensation
286000
us-gaap Share Based Compensation
ShareBasedCompensation
41000
us-gaap Depreciation
Depreciation
7000
us-gaap Depreciation
Depreciation
6000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
81000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1613000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
122000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-9000
us-gaap Inventory Write Down
InventoryWriteDown
-8000
tivc Gain On Paycheck Protection Program Loan Forgiveness
GainOnPaycheckProtectionProgramLoanForgiveness
157000
tivc Proceeds From Issuance Of Common Stock Warrants
ProceedsFromIssuanceOfCommonStockWarrants
52000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
68000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
332000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-462000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30000
tivc Proceeds From Deferred Offering Costs
ProceedsFromDeferredOfferingCosts
-79000
tivc Proceeds From Deferred Offering Costs
ProceedsFromDeferredOfferingCosts
-555000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
813000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
929000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
167000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-135000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-15000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6692000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2852000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-11000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2613000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
56000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2656000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6647000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-196000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12975000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1044000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6328000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
848000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1355000
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
244000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2600000
us-gaap Net Income Loss
NetIncomeLoss
-7800000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27400000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6300000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2600000
us-gaap Net Income Loss
NetIncomeLoss
-7800000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6300000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27400000
CY2022Q3 tivc Working Capital
WorkingCapital
5600000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of expenses during the reporting period. Actual results could differ materially from those estimates. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate.</span></p>
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2021Q4 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
82000
CY2022Q3 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
16000
CY2021Q4 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
16000
CY2022Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2022Q3 us-gaap Deferred Revenue
DeferredRevenue
0
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
3000
tivc Product Warranty Limited Period
ProductWarrantyLimitedPeriod
P1Y
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
12793000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12793000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Concentration of Credit Risk and Other Risks and Uncertainties</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">instruments that potentially subject the Company to significant concentrations of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents include accounts held at one financial institution in the United States. At times, such deposits may be in excess of insured limits. Management believes that the financial institution is financially sound, and accordingly, minimal credit risk exists with respect to the financial institution. The Company has not experienced any losses on its</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">deposits </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">of cash and cash equivalents. As of September 30, 2022 and December 31, 2021, the Company had cash and cash equivalents balances exceeding FDIC insured limits by $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">5.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million and $</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">12.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> million, respectively.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During 2022, the majority, or </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">80</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%, of the Company's sales have been to individual consumers. As of September 30, 2022, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reseller customers whose accounts receivable balances each totaled more than 10% or more of the Company’s total accounts receivable (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">69</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%) compared with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> such customers at December 31, 2021 (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the three months ended September 30, 2022, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reseller customer who individually accounted for 10% or more of the Company’s total revenue (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">22</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%). For the three months ended September 30, 2021, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reseller customers who individually accounted for 10% or more of the Company’s total revenue (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">28</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">For the nine months ended September 30, 2022, the Company had </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reseller customer who individually accounted for 10% or more of the Company’s total revenue (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">17</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%) compared with </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> reseller customers for the nine months ended September 30, 2021 (</span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% and </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">11</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">%).</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">During 2022, we outsourced </span><span style="font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">% of our contract manufacturing to one vendor in California.</span></p>
CY2022Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
5800000
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
12500000
tivc Percentage Of Outsource Of Contract Manufacturing
PercentageOfOutsourceOfContractManufacturing
1
CY2022Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
6000000
CY2022Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
6000000
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6000000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
6000000
CY2021Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
12793000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
12793000
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
6000000.0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
12800000
CY2022Q3 tivc Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2021Q4 tivc Fair Value Assets Level1 To Level2 Transfers Amount1
FairValueAssetsLevel1ToLevel2TransfersAmount1
0
CY2022Q3 tivc Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
CY2021Q4 tivc Fair Value Assets Level2 To Level1 Transfers Amount1
FairValueAssetsLevel2ToLevel1TransfersAmount1
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
645000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
281000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
116000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
148000
CY2022Q3 us-gaap Inventory Gross
InventoryGross
761000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
429000
CY2022Q3 us-gaap Inventory Net
InventoryNet
761000
CY2021Q4 us-gaap Inventory Net
InventoryNet
429000
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
88000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
724000
CY2022Q3 tivc Refundable Research And Development Tax Credit
RefundableResearchAndDevelopmentTaxCredit
113000
CY2021Q4 tivc Refundable Research And Development Tax Credit
RefundableResearchAndDevelopmentTaxCredit
37000
CY2022Q3 us-gaap Deposits Assets Current
DepositsAssetsCurrent
15000
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
7000
CY2022Q3 us-gaap Other Assets
OtherAssets
115000
CY2021Q4 us-gaap Other Assets
OtherAssets
25000
CY2022Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
331000
CY2021Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
793000
CY2021Q4 us-gaap Area Of Land
AreaOfLand
9091
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The lease will expire in October 2025 and there is no option to renew for an additional term.
tivc Lessee Operating Leases Expiration Month And Year
LesseeOperatingLeasesExpirationMonthAndYear
2025-10
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
false
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
50000
us-gaap Operating Lease Cost
OperatingLeaseCost
151000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
0
us-gaap Operating Lease Cost
OperatingLeaseCost
0
CY2022Q3 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P3Y
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.060
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
50000
us-gaap Operating Lease Payments
OperatingLeasePayments
138000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
0
us-gaap Operating Lease Payments
OperatingLeasePayments
0
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
34000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
206000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
210000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
178000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
628000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
55000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
573000
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
93750
us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
272680
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
272680
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1248850
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
607220
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
476381
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
707250
CY2022Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1997911
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
1587150
CY2022Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
280000
CY2021Q4 tivc Warrants Or Rights Fair Value Assumptions Method Used
WarrantsOrRightsFairValueAssumptionsMethodUsed
Black-Scholes options valuation model
CY2021Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
328000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2021 tivc Percentage Of Number Of Shares Added Each Year
PercentageOfNumberOfSharesAddedEachYear
0.050
CY2021Q4 tivc Percentage Of Number Of Shares Added Each Year
PercentageOfNumberOfSharesAddedEachYear
0.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
607220
CY2021Q4 tivc Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price On Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePriceOnOutstanding
280090
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
716630
tivc Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Grants In Period On Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableGrantsInPeriodOnGross
47477
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
18750
tivc Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableForfeituresInPeriod
18750
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56250
tivc Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercised
56250
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1248850
CY2022Q3 tivc Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price On Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePriceOnOutstanding
252567
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.01
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.62
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
100781
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
7031
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
93750
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
113000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
286000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1521530
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2654085
CY2022Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
5000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
18000
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0

Files In Submission

Name View Source Status
0000950170-22-025033-index-headers.html Edgar Link pending
0000950170-22-025033-index.html Edgar Link pending
0000950170-22-025033.txt Edgar Link pending
0000950170-22-025033-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img40100271_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tivc-20220930.htm Edgar Link pending
tivc-20220930.xsd Edgar Link pending
tivc-ex31_1.htm Edgar Link pending
tivc-ex31_2.htm Edgar Link pending
tivc-ex32_1.htm Edgar Link pending
tivc-20220930_lab.xml Edgar Link unprocessable
tivc-20220930_pre.xml Edgar Link unprocessable
tivc-20220930_htm.xml Edgar Link completed
tivc-20220930_cal.xml Edgar Link unprocessable
tivc-20220930_def.xml Edgar Link unprocessable